Literature DB >> 1764427

Interpositional polytetrafluoroethylene grafts. Conjunctival biocompatibility.

J W Karesh1, M A Fabrega, M M Rodrigues.   

Abstract

Polytetrafluoroethylene (PTFE) is a synthetic, woven, nonabsorbable, nonantigenic, Teflon-related material that has been shown to be useful in correcting eyelid retraction and as an implant enveloping material in primary and secondary surgery to correct anophthalmos. Implanted PTFE will extrude if not entirely covered with a layer of conjunctival epithelium. In vitro studies demonstrated that coating PTFE with collagen, fibronectin, gelatin, or laminin promotes epithelial cell and fibroblast migration over and adherence to PTFE. In vivo studies showed that a coating of type 1 collagen is most successful in preventing graft extrusion by promoting conjunctival epithelial attachment and growth over exposed PTFE. Further studies are needed to determine the optimum PTFE coating and pore size needed to ensure the consistent retention of uncovered implanted PTFE grafts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764427     DOI: 10.1097/00002341-199112000-00008

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  Rigid nylon foil-anchored polytetrafluoroetyhlene (Gore-Tex) sheet stenting for conjunctival fornix reconstruction.

Authors:  Hakan Demirci; Susan G Elner; Victor M Elner
Journal:  Ophthalmology       Date:  2010-08-05       Impact factor: 12.079

2.  Management of complicated multirecurrent pterygia using multimicroporous expanded polytetrafluoroethylene.

Authors:  Kyoung Woo Kim; Jae Chan Kim; Jun Hyung Moon; Hyun Koo; Tae Hyung Kim; Nam Ju Moon
Journal:  Br J Ophthalmol       Date:  2013-03-15       Impact factor: 4.638

3.  Application of polycaprolactone nanofibers as patch graft in ophthalmology.

Authors:  Hassan Hashemi; Soheila Asgari; Saied Shahhoseini; Mirgholamreza Mahbod; Fatemeh Atyabi; Haleh Bakhshandeh; Amir Houshang Beheshtnejad
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.